Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors

NCT06933069 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Malignancies

Interventions

DRUG: CMAB017

Sponsor

Taizhou Mabtech Pharmaceutical Co.,Ltd